| You are not signed in | Contact Us | Home | Login/Register |
Home » Primary Care Forum » Selection Panel
| Primary Care Forum Panel | |
| The panelists have disclosed the following and all conflicts of interest have been resolved. | |
| Chair | |
| Peter P Toth, M.D., Ph.D., FAAFP, FICA, FAHA, FACC | Director of Preventive Cardiology Sterling Rock Falls Clinic, Ltd. Chief of Medicine, CGH Medical Center Visiting Clinical Associate Professor University of Illinois School of Medicine Editor-in-Chief, Journal of Applied Research in Clinical and Experimental Therapeutics*2010 this panel member is not an active content provider* Peter P Toth, M.D., Ph.D., FAAFP, FICA, FAHA, FACC has openly disclosed that s/he: is on the Speaker's Bureau for Abbott, AstraZeneca, Pfizer, Merck, Schering Plough, Takeda and GlaxoSmithKline; is a consultant for AstraZeneca, Merck, Schering-Plough and Pfizer; and has resolved all relevant conflicts of interest. |
| Panel | |
| Annemarie Armani, MD | Senior Medical Director Imprint Science Managing Editor of Critical Pathways in Cardiology Executive Editor of Contemporary Cardiology *2008 this member is not an active content provider* Annemarie Armani, MD has documented that he/she has nothing to disclose. |
| Jerry M Blaine, MD | Senior Staff Internist Dept. of General Internal Medicine Lahey Clinic Medical Center *2008 this member is not an active content provider* Jerry M Blaine, MD has openly disclosed that s/he: has grant/research support from Pfizer and AstraZeneca; is on the Speaker's Bureau for Pfizer, AstraZeneca, Merck, Schering Plough and KOS; is a consultant for AstraZeneca; and has resolved all relevant conflicts of interest. |
| Michael J Bloch, MD | Assistant Professor of Medicine Division of General Internal Medicine, Dept. of Internal Medicine University of Nevada School of Medicine Michael J Bloch, MD has openly disclosed that s/he: has grant/research support from AstraZeneca, Novartis and Bayer; is on the Speaker's Bureau for AstraZeneca, Novartis, Pfizer and Sanofi; is a consultant for AstraZeneca; and has resolved all relevant conflicts of interest. |
| Eliot A Brinton, MD | Cardiovascular Genetics University of Utah *2008 this member is not an active content provider* Eliot A Brinton, MD has openly disclosed that s/he: has grant/research support from Pfizer, Merck, Schering Plough, Astra Zeneca and Sanofi Aventis; is on the Speaker's Bureau for Glaxo Smithkline, Takeda, Pfizer, Merck, Schering Plough, Astra Zeneca, Sanofi Aventis and Reliant; and has resolved all relevant conflicts of interest. |
| Michael B Clearfield, DO, FACOI | Professor and Chairman Department of University of North Texas Health Science Center of Medicine Michael B Clearfield, DO, FACOI has openly disclosed that s/he: has grant/research support from AstraZeneca and Roche; is on the Speaker's Bureau for AstraZenece, Pfizer, Merck and Sankyo*2010 this panel member is not an active content provider*; is a consultant for AstraZenece, Pfizer, Merck and Sankyo; and has resolved all relevant conflicts of interest. |
| William Cromwell, MD | Chief, Division of Lipoprotein Disorders Presbyterian Center for Preventive Cardiology Presbyterian Cardiovascular Institute Adjunct Associate Professor Hypertension and Vascular Disease Center Wake Forest University School of Medicine *2010 this panel member is not an active content provider* William Cromwell, MD has openly disclosed that s/he: is on the Speaker's Bureau for Merck, Shering Plough, KOS, Abbott, LipoScience and Inc.; is a consultant for LipoScience and Inc.; and has resolved all relevant conflicts of interest. |
| Thomas Dayspring, MD, F.A.C.P. | Clinical Assistant Professor of Medicine University of Medicine and Dentistry of New Jersey New Jersey Medical School Diplomate American Board of Clinical Lipidology Director: North Jersey Institute of Menopausal Lipidology*2010 this panel member is not an active content provider* Thomas Dayspring, MD, F.A.C.P. has openly disclosed that s/he: is on the Speaker's Bureau for Astra Zeneca, Reliant, Abbott, Merck, Schering Plough and Sanofi-Aventis; is a consultant for Abbott and Reliant; and has resolved all relevant conflicts of interest. |
| Darwin Deen, MD, MS | Dept of Family Medicine and Community Health Albert Einstein College of Medicine *2010 this member is not an active content provider* Darwin Deen, MD, MS has documented that he/she has nothing to disclose. |
| Paul E Fenster, MD, FACC | Professor of Medicine University of Arizona College of Medicine Sarver Heart Center *2010 this member is not an active content provider* Paul E Fenster, MD, FACC has openly disclosed that s/he: is on the Speaker's Bureau for AstraZeneca, Merck and Pfizer; and has resolved all relevant conflicts of interest. |
| Peter Jones, MD | Associate Professor of Medicine Section Of Atherosclerosis and Lipid Research Baylor College of Medicine *2010 this member is not an active content provider* Peter Jones, MD has openly disclosed that s/he: has grant/research support from KOS, Abbott, AstraZeneca and Pfizer; is on the Speaker's Bureau for AstraZeneca; is a consultant for Abbott; and has resolved all relevant conflicts of interest. |
| Jennifer G Robinson, MD MPH | Associate Professor Director, Lipid Research Clinic Departments of Epidemiology & Medicine College of Public Health University of Iowa *2008 this member is not an active content provider* Jennifer G Robinson, MD MPH has openly disclosed that s/he: has grant/research support from Pfizer, Merck/Schering Plough, Hoffman La Roche, Astra Zeneca, Wyeth Ayerst, Bristol Myers Squibb, Atherogenics, Proctor and Gamble, Glaxo Smith Kline, Sankyo and Abbott; and has resolved all relevant conflicts of interest. |
| James A Underberg, MS, MD | Preventive Cardiovascular Medicine Clinical Assistant Professor of Medicine Division of General Internal Medicine, NYU Medical School Fellow Society Vascular Medicine & Biology ASH Specialist in Clinical Hypertension Diplomate American Board of Clinical LIpidology NAMS Certified Menopause Practitioner *2010 this member is not an active content provider* James A Underberg, MS, MD has openly disclosed that s/he: has grant/research support from Astra Zeneca and Glaxo SmithKline; is on the Speaker's Bureau for Liposcience, Sankyo, Pfizer and Astra Zeneca; is a consultant for Liposcience; and has resolved all relevant conflicts of interest. |
| Guest Panel | |
| Graciela S. Alarcon, M.D., M.P.H. | Jane Knight Lowe Chair of Medicine in Rheumatology University of Alabama at Birmingham Birmingham, AL Graciela S. Alarcon, M.D., M.P.H. has documented that he/she has nothing to disclose. |
| Christie M. Ballantyne, M.D. | Director of the Center for Cardiovascular Disease Prevention Chief, Section of Atherosclerosis and Vascular Medicine Methodist DeBakey Heart Center Baylor College of Medicine Houston, TX Christie M. Ballantyne, M.D. has openly disclosed that s/he: has grant/research support from AstraZeneca, Merck, Schering Plough, Pfizer, DiaDexus, Gene Logic, GSK, Integrated Therapeutics, KOS, Merck, Novartis, Reliant, Sankyo, Schering-Plough and Sanofi Syntleabo; is on the Speaker's Bureau for AstraZeneca, Merck, Pfizer, Relient, KOS and Schering-Plough; is a consultant for AstraZeneca, Bayer, Merck, Pfizer, Relient, Novaris, Schering-Plough and Sanofi Synthelabo; and has resolved all relevant conflicts of interest. |
| Vera Bittner, M.D., M.S.P.H. | Professor of Medicine Section Head, Preventive Cardiology Department of Medicine University of Alabama at Birmingham Division of Cardiovascular Disease Birmingham, AL Vera Bittner, M.D., M.S.P.H. has openly disclosed that s/he: has grant/research support from Pfizer, Atherogenics, NIH/Abbott, Merck, CV Therapeutics, Reliant, Novartis and ; is a consultant for Pfizer, CV Therapeutics, Reliant and Novartis*2010 this panel member is not an active content provider*; and has resolved all relevant conflicts of interest. |
| Roger Blumenthal, M.D., F.A.C.C. | Associate Professor of Medicine Director, The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease Baltimore, MD Roger Blumenthal, M.D., F.A.C.C. has documented that he/she has nothing to disclose. |
| Christopher P. Cannon, M.D. | Associate Professor of Medicine Harvard Medical School Cardiovascular Division Brigham and Women's Hospital Boston, MA Christopher P. Cannon, M.D. has openly disclosed that s/he: has grant/research support from Accumetrics, Merck, Sanofi-Aventis, Glaxo SmithKline, Bristol Myers Squibb and AstraZeneca and Schering-Plough; is a consultant for Automedics Medical Systems; and has resolved all relevant conflicts of interest. |
| Robert J. Chilton, D.O., F.A.C.C. | Associate Professor of Medicine The University of Texas Health Science Center Director, Cardiac Catheterization Laboratory and Electrophysiology Audie L. Murphy Memorial Veterans Hospital San Antonio, Texas Robert J. Chilton, D.O., F.A.C.C. has openly disclosed that s/he: is on the Speaker's Bureau for Glaxo SmithKline, Pfizer and Takeda; is a consultant for Glaxo SmithKline, Pfizer and Takeda; and has resolved all relevant conflicts of interest. |
| Peter Clayton, M.D. | Professor of Child Health and Pediatric Endocrinology University of Manchester Manchester, UK *2010 this member is not an active content provider* Peter Clayton, M.D. has openly disclosed that s/he: has grant/research support from Novo-Nordisk, UK and Serono UK; and has resolved all relevant conflicts of interest. |
| Jerome D. Cohen, M.D. | Professor of Medicine Saint Louis University Health Sciences Center Division of Cardiology St. Louis, MO Jerome D. Cohen, M.D. has openly disclosed that s/he: is a consultant for Merck and Company; and has resolved all relevant conflicts of interest. |
| David M. Cook, M.D. | Professor of Medicine Oregon Health and Science University Portland, OR David M. Cook, M.D. has openly disclosed that s/he: has grant/research support from Pfizer, Genentech, Eli Lilly and Indevus; is on the Speaker's Bureau for Lilly, Pfizer, Genentech and Novo Nordisk; is a consultant for Novo Nordisk; and has resolved all relevant conflicts of interest. |
| Anne B. Curtis, M.D. | Professor of Medicine Chief, Division of Cardiology Director and CEO, Cardiovascular Services University of South Florida Tampa, Florida Anne B. Curtis, M.D. has openly disclosed that s/he: has grant/research support from Medtronic and St. Jude Medical; is on the Speaker's Bureau for Medtronic, Boston Scientific, St. Jude Medical and Biotronic; is a consultant for Medtronic, St. Jude Medical, Biosense Webster and Sanofi Aventis; and has resolved all relevant conflicts of interest. |
| John J. Cush, M.D. | Chief, Rheumatology and Clinical Immunology Presbyterian Hospital of Dallas Clinical Professor of Internal Medicine The University of Texas Southwestern Medical School Dallas, TX *2010 this member is not an active content provider* John J. Cush, M.D. has documented that he/she has nothing to disclose. |
| Paresh Dandona, MBBS, D. Phil., FRCP, FACP, FACC, FACE | Director, Diabetes-Endocrinology Center of WNY Distinguished Professor of Medicine Chief of the Division of Endocrinology SUNY at Buffalo *2010 this member is not an active content provider* Paresh Dandona, MBBS, D. Phil., FRCP, FACP, FACC, FACE has openly disclosed that s/he: has grant/research support from Neurocrine, NCSS, Astra Zeneca, Sanwa, Lilly, IDD, Biostratum, Wyeth Ayerst, Roche, Pharmacia, GlaxoSmithKline, Pfizer, Novartis, NovoNordisk, Merck, Medifacts International, Bristol Meyers Squibb, Abbott and Takeda; and has resolved all relevant conflicts of interest. |
| Michael H. Davidson, M.D. | Associate Professor of Medicine Director of Preventive Cardiology, at Rush Medical College Rush University Medical Center President/CEO Executive Medical Director Chicago Center for Clinical Research Radiant Research Chicago, IL *2010 this member is not an active content provider* Michael H. Davidson, M.D. has openly disclosed that s/he: has grant/research support from Abbott, AstraZeneca, BMS, KOS, Merck, Schering-Plough, Pfizer, Novartis, Reliant, Sankyo, Sumitomo and Takeda; is on the Speaker's Bureau for Abbott, AstraZeneca, BMS, KOS, Merck, Schering-Plough, Pfizer, Novartis, Reliant, Sankyo, Sumitomo and Takeda; is a consultant for Abbott, AstraZeneca, BMS, KOS, Merck, Schering-Plough, Pfizer, Novartis, Reliant, Sankyo, Sumitomo and Takeda; and has resolved all relevant conflicts of interest. |
| Maxime Dougados, M.D. | Professor of Rheumatology Hospital Cochin Rene Descartes University Paris, France *2010 this member is not an active content provider* Maxime Dougados, M.D. has documented that he/she has nothing to disclose. |
| George S. Eisenbarth, M.D., Ph.D. | Professor Pediatrics, Medicine and Immunology University of Colorado Health Sciences Center Executive Director, Barbara Davis Center for Childhood Diabetes Denver, CO George S. Eisenbarth, M.D., Ph.D. has openly disclosed that s/he: is a consultant for Roche (ad hoc) ; and has resolved all relevant conflicts of interest. |
| Melinda Epperson, Director - Tulane, CCE | Melinda Epperson, Director - Tulane, CCE has openly disclosed that s/he: has grant/research support from nothing to disclose; is on the Speaker's Bureau for nothing to disclose; is a consultant for nothing to disclose; and has resolved all relevant conflicts of interest. |
| Vivian A. Fonseca, M.D. | Professor of Medicine and Pharmacology Tullis - Tulane Alumni Chair in Diabetes Chief, Section of Endocrinology Tulane University Health Sciences Center New Orleans, LA Vivian A. Fonseca, M.D. has openly disclosed that s/he: has grant/research support from Eli Lilly, Takeda, Glaxo Smith Kline, Novartis, Novo-Nordisk, Astra Zeneca, Sanofi-Aventis, Daiichi-Sankyo, NIH and ADA ; is on the Speaker's Bureau for Eli Lilly, Takeda, Glaxo Smith Kline, Novartis and Sanofi-Aventis; is a consultant for Eli Lilly, Takeda, Glaxo Smith Kline, Novartis, Sanofi-Aventis and .Daiichi Sankyo; and has resolved all relevant conflicts of interest. |
| David A. Fox, M.D. | Professor of Internal Medicine Chief, Division of Rheumatology University of Michigan Ann Arbor, MI David A. Fox, M.D. has openly disclosed that s/he: is a consultant for Guidepoint Global Advisors; and has resolved all relevant conflicts of interest. |
| Saul Genuth, M.D. | Professor of Medicine Case Western Reserve University Saul Genuth, M.D. has openly disclosed that s/he: has grant/research support from Glaxo Smith Kline; and has resolved all relevant conflicts of interest. |
| Kerry Gorman, Director - Bioexpertise | Kerry Gorman, Director - Bioexpertise has openly disclosed that s/he: has grant/research support from nothing to disclose; is on the Speaker's Bureau for nothing to disclose; is a consultant for nothing to disclose; and has resolved all relevant conflicts of interest. |
| Barry H. Greenberg, M.D. | Professor of Medicine Director, Heart Failure/Cardiac Transplantation Program University of California, San Diego San Diego, CA *2008 this member is not an active content provider* Barry H. Greenberg, M.D. has openly disclosed that s/he: is on the Speaker's Bureau for GSK, Merck and Pfizer; is a consultant for GSK and CHF Solutions; and has resolved all relevant conflicts of interest. |
| Steven M. Haffner, M.D. | Professor of Internal Medicine University of Texas Health Science Center Division of Clinical Epidemiology San Antonio, TX *2010 this panel member is not an active content provider* Steven M. Haffner, M.D. has openly disclosed that s/he: is on the Speaker's Bureau for Merck, Pfizer, Lilly and Glaxo Smith Kline Novartis; and has resolved all relevant conflicts of interest. |
| Dana Hardin, M.D. | Section Chief of Pediatric Endocrinology The Ohio State University Columbus, OH Dana Hardin, M.D. has openly disclosed that s/he: has grant/research support from Pfizer, Tercica, USDA and Ispen; is on the Speaker's Bureau for Roche and Veraxis; is a consultant for Ispen; and has resolved all relevant conflicts of interest. |
| Robert R. Henry, M.D. | Chief, Section of Endocrinology, Metabolism & Diabetes VA San Diego Healthcare System San Diego, CA *2010 this member is not an active content provider* Robert R. Henry, M.D. has openly disclosed that s/he: has grant/research support from Takeda, Eli Lilly, Pfizer, Merck, Aventis, Amylin, Glaxo Smith Kline and Novo Nordisk; is on the Speaker's Bureau for Takeda, Eli Lilly, Pfizer, Merck, Aventis, Amylin, Glaxo Smith Kline and Novo Nordisk; is a consultant for Takeda, Eli Lilly, Pfizer, Merck, Aventis, Amylin, Glaxo Smith Kline and Novo Nordisk; and has resolved all relevant conflicts of interest. |
| Andrew R. Hoffman, M.D. | Professor of Medicine Division of Endocrinology, Gerontology and Metabolism Stanford University Palo Alto, CA Andrew R. Hoffman, M.D. has openly disclosed that s/he: has grant/research support from Genentech; is a consultant for LG Bioscience, Genentech, Ambrx and Teva; and has resolved all relevant conflicts of interest. |
| Rury R. Holman, M.B., Ch.B, F.R.C.P. | Professor of Diabetic Medicine Diabetes Trial Unit Oxford Centre for Diabetes, Endocrinology and Metabolism Oxford, UK *2010 this member is not an active content provider* Rury R. Holman, M.B., Ch.B, F.R.C.P. has documented that he/she has nothing to disclose. |
| Edward S. Horton, M.D. | Director of Clinical Research Joslin Diabetes Center Boston, MA *2010 this member is not an active content provider* Edward S. Horton, M.D. has openly disclosed that s/he: has grant/research support from Pfizer, Takeda and Novartis Roche; is a consultant for Pfizer, Takeda, Novartis, Merck, Bayer, Novo Nordisk and Lilly; and has resolved all relevant conflicts of interest. |
| Ami E. Iskandrian, M.D. | Professor of Medicine and Radiology Section Chief of Nuclear Cardiology Division of Cardiovascular Disease University of Alabama at Birmingham Birmingham, AL Ami E. Iskandrian, M.D. has openly disclosed that s/he: has grant/research support from CV Therapeutics and Astellas; is a consultant for CV Therapeutics and Astellas; and has resolved all relevant conflicts of interest. |
| Steven E. Kahn, M.B., Ch.B. | Professor of Medicine Division of Metabolism, Endocrinology and Nutrition University of Washington VA Puget Sound Health Care System Seattle, WA *2010 this member is not an active content provider* Steven E. Kahn, M.B., Ch.B. has openly disclosed that s/he: has grant/research support from GlaxoSmithKline Novartis; is a consultant for Merck Amylin GlaxoSmithKline Novartis; and has resolved all relevant conflicts of interest. |
| John J. P. Kastelein, M.D., Ph.D. | Professor of Internal Medicine Academic Medical Center Department of Vascular Medicine Amsterdam, The Netherlands John J. P. Kastelein, M.D., Ph.D. has documented that he/she has nothing to disclose. |
| Laurence Katznelson , M.D. | Associate Professor of Neurosurgery and Medicine Stanford Univeristy School of Medicine Stanford, California *2010 this member is not an active content provider* Laurence Katznelson , M.D. has documented that he/she has nothing to disclose. |
| Lyndon Key, M.D. | Professor and Chairman Department of Pediatrics Children’s Hospital of the Medical University of South Carolina Charleston, SC *2010 this member is not an active content provider* Lyndon Key, M.D. has openly disclosed that s/he: has grant/research support from Merck; is a consultant for National Cooperative Growth Study and Genentech; and has resolved all relevant conflicts of interest. |
| David Kleinberg, M.D. | Professor of Medicine NYU School of Medicine Deparment of Medicine New York, NY *2010 this member is not an active content provider* David Kleinberg, M.D. has openly disclosed that s/he: has grant/research support from Novartis; is on the Speaker's Bureau for Eli Lilly; is a consultant for Novartis and Eli Lilly; and has resolved all relevant conflicts of interest. |
| Nasser Lakkis, M.D. | Associate Professor of Medicine Director of the Invasive Laboratory Ben Taub Hospital Houston, TX *2010 this member is not an active content provider* Nasser Lakkis, M.D. has openly disclosed that s/he: is on the Speaker's Bureau for Merck, Bristol Meyers Squibb and Sanofi; and has resolved all relevant conflicts of interest. |
| Harold E. Lebovitz, M.D. | Professor of Medicine SUNY-Downstate Medical Center Staten Island, NY *2010 this member is not an active content provider* Harold E. Lebovitz, M.D. has openly disclosed that s/he: has grant/research support from Glaxo Smith Kline , Novo Nordisk and Pfizer; is on the Speaker's Bureau for Bayer, Bristol Meyers Squibb and Glaxo Smith Kline; is a consultant for Aventis, Bayer, Glaxo Smith Kline, Novo Nordisk , Pfizer, Takeda and .Amylin; and has resolved all relevant conflicts of interest. |
| Desmond Mascarenhas, CEO - Bioexpertise | Desmond Mascarenhas, CEO - Bioexpertise has openly disclosed that s/he: has grant/research support from nothing to disclose; is on the Speaker's Bureau for nothing to disclose; is a consultant for nothing to disclose; and has resolved all relevant conflicts of interest. |
| Larry W. Moreland, M.D. | Chief, Division of Rheumatology and Clinical Immunology University of Pittsburgh Margaret Jane Milleer Endowed Professor of Arthritis Research Larry W. Moreland, M.D. has openly disclosed that s/he: is on the Speaker's Bureau for Genentech and Bristol Meyers Squibb; is a consultant for Genentech, Bristol Meyers Squibb, Roche and Pfizer; and has resolved all relevant conflicts of interest. |
| Sharon Morrill, Director - Bioexpertise | Sharon Morrill, Director - Bioexpertise has openly disclosed that s/he: has grant/research support from nothing to disclose; is on the Speaker's Bureau for nothing to disclose; is a consultant for nothing to disclose; and has resolved all relevant conflicts of interest. |
| Gerald V. Naccarelli, M.D. | Chief, Division of Cardiology Bernard Trabin Chair in Cardiology Penn State University College of Medicine The Milton S. Hershey Medical Center Hershey, PA Gerald V. Naccarelli, M.D. has openly disclosed that s/he: has grant/research support from SanofiAventis, Medtronic, Guidant, St. Jude, Boston Scientific, Reliant and Boehringer Ingelheim; is a consultant for SanofiAventis, Wyeth-Ayerst, Pfizer, Medtronic, Guidant, Reliant, AstraZeneca Novartis and Glaxo Smithkline; and has resolved all relevant conflicts of interest. |
| Anders G. Olsson, M.D., Ph.D. | Professor of Internal Medicine IMV University Hospital Linkoping, Sweden *2010 this member is not an active content provider* Anders G. Olsson, M.D., Ph.D. has openly disclosed that s/he: is a consultant for AstraZeneca, Merck, Schering Plough and Merck-Germany; and has resolved all relevant conflicts of interest. |
| Edward O. Reiter, M.D. | Professor of Pediatrics Tufts University School of Medicine Chairman, Department of Pediatrics lBaystate Children's Hospital Springfield, MA Edward O. Reiter, M.D. has openly disclosed that s/he: has grant/research support from Endo Pharm and Novo Nordisk; is a consultant for Novo Nordisk, Endo and Astra Zeneca; and has resolved all relevant conflicts of interest. |
| Alan D. Rogol M.D., Ph.D. | Professor of Clinical Pediatrics University of Virginia Charlottesville, VA *2010 this member is not an active content provider* Alan D. Rogol M.D., Ph.D. has documented that he/she has nothing to disclose. |
| Christy Sandborg, M.D. | Department of Pediatrics
Stanford University Medical Center *2010 this member is not an active content provider* Christy Sandborg, M.D. has documented that he/she has nothing to disclose. |
| Ernst J. Schaefer, M.D. | Professor of Medicine Director, Lipid and Heart Disease Prevention Program New England Medical Center Boston, MA *2010 this member is not an active content provider* Ernst J. Schaefer, M.D. has openly disclosed that s/he: has grant/research support from Pfizer, AstraZeneca and Kos; is on the Speaker's Bureau for Pfizer, AstraZeneca, Kos and Merck; is a consultant for Pfizer, AstraZeneca, Kos, Merck and Abbott; and has resolved all relevant conflicts of interest. |
| Janie Soslow, Senior Program Coordinator - Tulane CCE | Janie Soslow, Senior Program Coordinator - Tulane CCE has openly disclosed that s/he: has grant/research support from nothing to disclose; is on the Speaker's Bureau for nothing to disclose; is a consultant for nothing to disclose; and has resolved all relevant conflicts of interest. |
| W. H. Wilson Tang, M.D. | Clinical Associate Staff Kaufman Center for Heart Failure Cleveland Clinic Foundation Cleveland, Ohio *2010 this member is not an active content provider* W. H. Wilson Tang, M.D. has openly disclosed that s/he: has grant/research support from GSK; is on the Speaker's Bureau for GSK, Takeda and Medtronic; is a consultant for GSK, Amylin, Medimmune and Medtronic; and has resolved all relevant conflicts of interest. |
| Peter Trainer, M.D. | Consultant Endocrinologist Department of Endocrinology Christie Hospital Manchester, UK *2010 this member is not an active content provider* Peter Trainer, M.D. has openly disclosed that s/he: has grant/research support from Pharmacia, Novartis and Ispen; is a consultant for Pharmacia; and has resolved all relevant conflicts of interest. |
| Sally Vander Veer, VP, Operations - Bioexpertise | Sally Vander Veer, VP, Operations - Bioexpertise has openly disclosed that s/he: has grant/research support from nothing to disclose; is on the Speaker's Bureau for nothing to disclose; is a consultant for nothing to disclose; and has resolved all relevant conflicts of interest. |
| Arthur L. Weaver, M.D., M.S., F.A.C.P., M.A.C.R. | Clinical Professor of Medicine University of Nebraska Medical Center Omaha, Nebraska Arthur L. Weaver, M.D., M.S., F.A.C.P., M.A.C.R. has openly disclosed that s/he: is on the Speaker's Bureau for Abbott, Amgen, Aventis, Bristol-Meyers-Squibb, Centocor, Cypress BioScience, Genetech, Lilly, Merck, Novartis, Pfizer, Primus Pharmaceuticals, Takeda, Theraquest, and Wyeth, Human Genome Science, Horizion, Alpharma, NicOx, Roche, Biogen Idec, Endo and Saveint; is a consultant for Abbott, Amgen, Bristol-Meyers-Squibb, l Centocor, Cypress BioScience, Genetech, Lilly, Merck, Novartis, Pfizer, Primus Pharmaceuticals, Takeda, Theraquest, Wyeth, Human Genome Science, Horizion, Alpharma, NicOx, Roche, Biogen Idec, Endo and Saveint; and has resolved all relevant conflicts of interest. |
| Kathleen Wyne, M.D., Ph.D., F.A.C.E. | Director of Clinical Research Diabetes Research Center, The Methodist Hospital Research Institiute Weill Medical College, Cornell University The Methodist Hostpital Houston, TX Kathleen Wyne, M.D., Ph.D., F.A.C.E. has openly disclosed that s/he: is on the Speaker's Bureau for Novartis, Boehringer Ingelheim and Abbott; and has resolved all relevant conflicts of interest. |
| Copyright (C) 2008 Bioexpertise, Inc. All rights reserved. | Need Help? Terms. Privacy. CME Faculty. |